EcoDrugPlus

Ensembl ID : ENSOMYG00000057411
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000057705
Gene Symbol: -
Cross references: -
374 Possible Orthologues:

Ensembl ID : ENSOMYG00000021097
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSOMYG00000057258
Gene Symbol: -
Cross references: -
419 Possible Orthologues:

Ensembl ID : ENSOMYG00000021076
Gene Symbol: -
1 Cross references
208 Possible Orthologues:

Ensembl ID : ENSOMYG00000064551
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSOMYG00000065205
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOMYG00000065334
Gene Symbol: -
Cross references: -
279 Possible Orthologues:

Ensembl ID : ENSOMYG00000065373
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000065511
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSOMYG00000064619
Gene Symbol: -
Cross references: -
353 Possible Orthologues:

Ensembl ID : ENSOMYG00000071710
Gene Symbol: -
Cross references: -
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).